Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 801 to 850 of 2570

TitleReference numberPublishedLast updated
Pelvic floor dysfunction: prevention and non-surgical managementNG210
Olaparib for maintenance treatment of BRCA mutation-positive metastatic pancreatic cancer after platinum-based chemotherapy (terminated appraisal)TA750
Dupilumab for treating severe asthma with type 2 inflammationTA751
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndromeMIB281
Brain tumours (primary) and brain metastases in over 16sQS203
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal)TA749
Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disordersTA748
clonoSEQ for minimal residual disease assessment in multiple myeloma, acute lymphoblastic leukaemia and chronic lymphocytic leukaemiaMIB278
CerebAir for continuous EEG monitoring in intensive careMIB279
Paige Prostate for prostate cancerMIB280
Synergo for non-muscle-invasive bladder cancerHTG601
Fever in under 5s: assessment and initial managementNG143
Givosiran for treating acute hepatic porphyriaHST16
Percutaneous implantation of pulmonary artery pressure sensors for monitoring treatment of chronic heart failureHTG599
Coronary sinus narrowing device implantation for refractory anginaHTG600
Chronic kidney disease: assessment and managementNG203
SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoeaHTG598
Nivolumab for adjuvant treatment of resected oesophageal or gastro-oesophageal junction cancerTA746
Nintedanib for treating progressive fibrosing interstitial lung diseasesTA747
Heart valve disease presenting in adults: investigation and managementNG208
Acute heart failure: diagnosis and managementCG187
Upadacitinib for treating moderate rheumatoid arthritisTA744
NBTXR-3 for treating advanced soft tissue sarcoma (terminated appraisal)TA745
Inducing labourQS60
Inducing labourNG207
24/7 EEG SubQ for epilepsyMIB277
Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and managementNG206
Apalutamide with androgen deprivation therapy for treating high-risk hormone-relapsed non-metastatic prostate cancerTA740
Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancerTA741
Genicular artery embolisation for pain from knee osteoarthritisHTG595
Laparoscopic renal denervation for loin pain haematuria syndromeHTG596
Percutaneous endovascular forearm arteriovenous fistula creation for haemodialysis accessHTG597
Atezolizumab for untreated PD-L1-positive advanced urothelial cancer when cisplatin is unsuitableTA739
Tofacitinib for treating juvenile idiopathic arthritisTA735
Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapyTA736
Berotralstat for preventing recurrent attacks of hereditary angioedemaTA738
Looked-after children and young peopleNG205
Secukinumab for treating moderate to severe plaque psoriasis in children and young peopleTA734
Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemiaTA733
Baloxavir marboxil for treating acute uncomplicated influenza in people 12 years and over (terminated appraisal)TA732
DyeVert Systems for reducing the risk of acute kidney injury in coronary and peripheral angiographyHTG594
Avapritinib for treating unresectable or metastatic gastrointestinal stromal tumours (terminated appraisal)TA730
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)TA731
Transapical transcatheter mitral valve-in-ring implantation after failed annuloplasty for mitral valve repairHTG593
Lateral elbow resurfacing for arthritisHTG591
Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesisHTG592
Daratumumab with pomalidomide and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA726
Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal)TA727
Midostaurin for treating advanced systemic mastocytosisTA728
Sapropterin for treating hyperphenylalaninaemia in phenylketonuriaTA729

Results per page

  1. 10
  2. 25
  3. 50
  4. All